期刊
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
卷 35, 期 -, 页码 -出版社
BIOMED CENTRAL LTD
DOI: 10.1186/s13046-016-0463-3
关键词
Glioma; GANT61; Temozolomide; Hedgehog; DNA damage; O-6-methylguanine DNA methyltransferase (MGMT); Notch1 pathway
类别
资金
- Research Special Fund for Public Welfare Industry of Heath [201402008]
- National Key Research and Development Plan [2016YFC0902500]
- National Natural Scientific Fund [81572701, 81372700, 8140100730, 81572743]
- Special Fund Project of Translational Medicine in the Chinese-Russian Medical Research Center [CR201417]
- Research Project of Chinese Society of Neuro-oncology, CACA [CSNO-2014-MSD08]
- Postdoctoral Science Foundation of Heilongjiang Province [LBH-Z14220]
- Natural Scientific Fund of Heilongjiang Province [H201417]
- Research Project of the Health and Family Planning Commission of Heilongjiang Provincial [2013048]
Background: The aim of this study was to investigate the effect of downregulating Hedgehog pathway by GANT61 on human glioma cells, examine the consequent changes of temozolomide (TMZ)-induced effects and explore the molecular mechanisms. Methods: The cytotoxicity of a Gli1/2 inhibitor, GANT61 was examined both alone and in combination with TMZ in human glioma cell lines. The mRNA and protein expression alterations were determined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot, respectively. CCK-8 assay detected the cell proliferative capability. Apoptotic cell number was measured by flow cytometry. The transwell assay was used to test the cell invasive capability. DNA damage effect was identified by COMET assay and gamma H2AX expression. Results: Proliferation of tumor cells treated with GANT61 in combination with TMZ was significantly suppressed compared with those treated with either drug used alone. The combination treatment induced a higher rate of apoptosis, DNA damage and reduced the invasive capability of glioma cells. DNA damage repair enzyme MGMT and the Notch1 pathway increased in the cells treated by TMZ treatment. However, GANT61 could abrogated the protein increasing. Conclusions: GANT61 sensitizes glioma cells to TMZ treatment by enhancing DNA damage effect, decreasing MGMT expression and the Notch1 pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据